(Q40667325)

22 September 2017

Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo (English)

1 reference

22 September 2017

Carola Leuschner

1

1 reference

22 September 2017

Frederick M Enright

series ordinal

2

1 reference

22 September 2017

Barbara Gawronska

series ordinal

3

1 reference

22 September 2017

William Hansel

series ordinal

4

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Breast Cancer Research and Treatment

22 September 2017

1 reference

22 September 2017

78

1 reference

22 September 2017

1

1 reference

22 September 2017

17-27

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1022169525521

22 September 2017

0 references

cites work

Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

Tamoxifen to raloxifene and beyond

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

Expression of luteinizing hormone/human chorionic gonadotropin receptor gene in benign prostatic hyperplasia and in prostate carcinoma in humans

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

LHRH-receptors and LHRH-agonist treatment in ovarian cancer: an overview

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

Determinants of Transcription of the Chorionic Gonadotropin /Luteinizing Hormone Receptor Gene in Human Breast Cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

Hormonal regulation of luteinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian cells during follicular development and luteinization

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

Effects of LHRH-analogues on mitogenic signal transduction in cancer cells.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022169525521

7 January 2021

Identifiers

DOI

10.1023/A:1022169525521

1 reference

Dimensions Publication ID

22 September 2017

1026936364

0 references

Fatcat ID

release_obe2qjxlujfwbjnoh7sp46hq3u

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/obe2qjxlujfwbjnoh7sp46hq3u

24 November 2022

mapped directly with Wikidata item

1 reference